ISPOR - MT13 In-House Versus Send-out Next Generation Sequencing Testing for Metastatic Non-Small Cell Lung Cancer Patients. a Budget Impact Analysis

Full Text

MT13 In-House Versus Send-out Next Generation Sequencing Testing for Metastatic Non-Small Cell Lung Cancer Patients. a Budget Impact Analysis

Abstract

Authors

U. Silas Blüher M R. Dumanois R. Saunders

Back to Volume 26, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now